A new drug may help people with high blood pressure that does not respond to existing medications.
The results of a large clinical trial, published August 30 in the New England Journal of Medicine, suggest that baxdrostat could offer an alternative for people with resistant hypertension — high blood pressure that stays elevated despite standard therapy. Baxdrostat is one of a new class of drugs called aldosterone synthase inhibitors.
High blood pressure affects 1.3 billion people worldwide, yet 80 percent don’t get adequate treatment. Uncontrolled blood pressure increases the risk of stroke, heart attack and heart failure. Blood pressure itself is the force of blood pushing through your arteries.